经皮穴位电刺激合中医五音疗法改善肝郁脾虚型阈下抑郁状态的效应观察

注册号:

Registration number:

ITMCTR2024000176

最近更新日期:

Date of Last Refreshed on:

2024-08-06

注册时间:

Date of Registration:

2024-08-06

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

经皮穴位电刺激合中医五音疗法改善肝郁脾虚型阈下抑郁状态的效应观察

Public title:

Observation on effect of transcutaneous electrical acupoint stimulation combined with TCM five-tone therapy in improving subthreshold depression of liver-stagnation and spleen-deficiency type

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮穴位电刺激合中医五音疗法改善肝郁脾虚型阈下抑郁状态的效应观察

Scientific title:

Observation on effect of transcutaneous electrical acupoint stimulation combined with TCM five-tone therapy in improving subthreshold depression of liver-stagnation and spleen-deficiency type

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

VRLAB2023B03

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

全烨

研究负责人:

刘翼天

Applicant:

QUAN YE

Study leader:

LIU YITIAN

申请注册联系人电话:

Applicant telephone:

+86 180 9178 2880

研究负责人电话:

Study leader's telephone:

+86 158 1110 1170

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yeyeye0222@126.com

研究负责人电子邮件:

Study leader's E-mail:

lytbucm@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京市房山区阳光南大街与白杨东路交汇处东北角北京中医药大学良乡校区

研究负责人通讯地址:

北京市房山区阳光南大街与白杨东路交汇处东北角北京中医药大学良乡校区

Applicant address:

Liangxiang Campus of Beijing University of Chinese Medicine, Northeast corner of the intersection of South Sunshine Street and East Baiyang Road, Fangshan District, Beijing

Study leader's address:

Liangxiang Campus of Beijing University of Chinese Medicine, Northeast corner of the intersection of South Sunshine Street and East Baiyang Road, Fangshan District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京中医药大学

Applicant's institution:

Beijing University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2023BZYLL1412

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

北京中医药大学医学伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing University of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2023/12/31 0:00:00

伦理委员会联系人:

李梅、赵丽红

Contact Name of the ethic committee:

LI MEI&ZHAO LIHONG

伦理委员会联系地址:

北京市房山区拱辰街道北京中医药大学良乡校区

Contact Address of the ethic committee:

Liangxiang Campus, Beijing University of Chinese Medicine, Gongchen Street, Fangshan District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 5391 1431

伦理委员会联系人邮箱:

Contact email of the ethic committee:

llbgs@bucm.edu.cn

研究实施负责(组长)单位:

北京中医药大学

Primary sponsor:

Beijing University of Chinese Medicine

研究实施负责(组长)单位地址:

北京市房山区阳光南大街与白杨东路交汇处东北角北京中医药大学良乡校区

Primary sponsor's address:

Liangxiang Campus of Beijing University of Chinese Medicine, Northeast corner of the intersection of South Sunshine Street and East Baiyang Road, Fangshan District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京中医药大学

具体地址:

北京市房山区阳光南大街与白杨东路交汇处东北角北京中医药大学良乡校区

Institution
hospital:

Beijing University of Chinese Medicine

Address:

Liangxiang Campus of Beijing University of Chinese Medicine, Northeast corner of the intersection of South Sunshine Street and East Baiyang Road, Fangshan District, Beijing

经费或物资来源:

虚拟现实技术与系统全国重点实验室开放课题基金

Source(s) of funding:

Virtual reality technology and system national key laboratory open project fund

研究疾病:

阈下抑郁

研究疾病代码:

Target disease:

Subthreshold Depression

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

以TEAS为主要治疗方法,使用中医五音疗法协同增效,通过量表及舌脉诊数据明确不同治疗方案对肝郁脾虚型SD人群抑郁程度及中医证候的改变,通过脑电和fNIRS技术探讨TEAS和中医五音疗法改善SD状态的脑机制

Objectives of Study:

Taking TEAS as the main treatment method, five-tone therapy of traditional Chinese medicine was used to synergistic effect, and the changes of depression degree and TCM syndromes of SD patients with liver-stagnation and spleen-deficiency induced by different treatment programs were identified by scale and tongue and pulse data. The brain mechanism of improving SD state by tetrAS and five-tone therapy of traditional Chinese medicine was investigated by EEG and fNIRS techniques

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①年龄18~30岁,性别不限,右利手; ②符合阈下抑郁诊断标准,即大部分时间具有两种或两种以上的抑郁症状,持续两周以上,伴随有一定程度的社会功能损害,但达不到抑郁障碍的诊断标准; ③使用迷你国际神经精神病学访谈(The Mini International Neuro psychiatric Interview(MINIversion5.0)),确定不符合精神障碍诊断和统计手册第5版(Diagnostic and Statistical Manual of Mental Disorders-V,DSM-V)中抑郁症的诊断标准且无自杀倾向; ④17项汉密尔顿抑郁量表(HAMD-17)分数>7分,<17分; ⑤思虑过度,多疑善忧,时常叹气,食欲下降,消瘦,易疲劳,稍事活动便觉倦怠,脘痞暧气,月经不调,大便时溏时干,或咽中不适如有异物梗阻中任2项及2项以上症状; ⑥在过去6个月未接受任何抑郁症相关的治疗; ⑦ 知情同意,自愿参加。

Inclusion criteria

① Age is 18~30 years old, gender is not limited, right-handed; ② Meet the diagnostic criteria for subthreshold depression, that is, most of the time with two or more types of depressive symptoms, lasting for more than two weeks, accompanied by a certain degree of social function impairment, but can not meet the diagnostic criteria for depressive disorder; ③ Using the Mini International Neuropsychiatric Interview (The Mini International Neuro psychiatric Interview (MINIversion5.0)) to determine the diagnostic criteria for depression not suicidal in the Diagnostic and Statistical Manual of Mental Disorders Version 5 (Diagnostic and Statistical Manual of Mental Disorders-V, DSM-V); ④ 17-item Hamilton Depression Scale (HAMD-17) score> 7, <17; ⑤ Excessive thinking, suspicious and good worry, often sigh, decreased appetite, wasting, easy to fatigue, a little activity will feel tired, warm qi, irregular menstruation, loose stool, or pharyngeal discomfort such as foreign body obstruction in 2 or 2 symptoms; ⑥ Not receiving any depression-related treatment in the past 6 months; ⑦ Informed consent and voluntary participation.

排除标准:

① 根据DSM-V标准,满足心境障碍、双相抑郁障碍、精神障碍等的诊断标准; ② 既往精神疾病史或器质性精神障碍,或精神活性物质和非成瘾物质所致抑郁者; ③ 任何重大医学或神经疾病,头部外伤史; ④ 有内分泌紊乱(如库欣综合征、艾迪生氏病)等影响指标检测者; ⑤ 正在参与对本研究结果有影响的其它临床试验者。 如以上任何一个答案为“是”,此受试者不能参加。

Exclusion criteria:

① According to the DSM-V criteria, meet the diagnostic criteria of mood disorder, bipolar depression disorder, mental disorder and so on; ② Patients with a history of previous mental illness or organic mental disorders, or depression caused by psychoactive substances and non-addictive substances; ③ Any major medical or neurological disease, a history of head trauma; ④ Endocrine disorders (such as Cushing's syndrome, Addison's disease) and other influence indicators detection; ⑤ Other clinical trials currently influencing the results of the study. If any of the above answers are yes, this subject could not participate.

研究实施时间:

Study execute time:

From 2024-03-01

To      2025-06-30

征募观察对象时间:

Recruiting time:

From 2024-03-01

To      2024-11-30

干预措施:

Interventions:

组别:

经皮电+中医五音治疗组

样本量:

30

Group:

TAES+TCM five-tone therapy treatment group

Sample size:

干预措施:

在经皮电治疗的基础上采用背景五音传承文化有限公司的“空间场式播放设备”,选用肝郁脾虚证型相应的《春回大地》、《草木清新》、《心旷神怡》治疗曲目,以疏肝健脾,化痰散结,每次30min,每周2次,总疗程为4周。

干预措施代码:

Intervention:

on the basis of the percutaneous electrical treatment using the background five tone inheritance culture co., LTD. "space field type playback equipment", choose liver depression and spleen deficiency syndrome type corresponding "spring", "fresh vegetation", "refreshing" treatment songs, with liver spleen, phlegm, 30min each time, 2 times a week, the total course for 4 weeks.

Intervention code:

组别:

经皮穴位电刺激治疗组

样本量:

30

Group:

TAES treatment group

Sample size:

干预措施:

对受试者予一般心理健康教育,并在此基础上使用英迪KWD-808I电子脉冲经络理疗仪进行治疗,采用疏密波,频率取2/100Hz,波宽0.2ms,强度为10-50mA以受试者耐受为度;选取双侧内关穴、神门穴、足三里穴、太冲穴,分别贴上电极片。每次治疗持续30min,每周2次,总疗程为4周。

干预措施代码:

Intervention:

the subjects were given general mental health education, and on this basis, the KWD-808I electronic pulse meridian therapy instrument, with density wave, frequency of 2 / 100Hz, wave width of 0.2ms, and intensity of 10-50 mA for subject tolerance; Neiguan, Shenmen, Zusanli and Taichong points were selected, and electrodes were affixed respectively. Each treatment lasted for 30min, twice a week, with a total duration of 4 weeks.

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

予一般心理健康教育后不进行其他治疗。

干预措施代码:

Intervention:

General mental health education.

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京中医药大学

单位级别:

大学

Institution/hospital:

Beijing University of Chinese Medicine

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

汉密尔顿抑郁量表

指标类型:

主要指标

Outcome:

Hamilton Depression Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医证候积分表

指标类型:

主要指标

Outcome:

Traditional Chinese Medicine(TCM) syndrome scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

舌象

指标类型:

次要指标

Outcome:

Tongue image

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脉象

指标类型:

次要指标

Outcome:

pulse image

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

动态脑电

指标类型:

次要指标

Outcome:

Electroencephalogram(EEG)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

近红外脑功能成像

指标类型:

次要指标

Outcome:

Functional Near-infrared Spectroscopy(fNIRS)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

无(不采集标本)

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 30
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用区组随机方式,每6名入组受试者为一组,使用随机数字表法,按照1∶1∶1比例分成三组。随机数由软件SPSS 24.0 产生

Randomization Procedure (please state who generates the random number sequence and by what method):

One group of each 6 enrolled subjects with random numbers table was divided into three groups according to the ratio of 1:1:1. Random numbers were generated by the software SPSS 24.0.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2025.5.15,网络平台(http://www.ncbi.nlm.nih.gov/)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2025.5.15, web-based public database(http://www.ncbi.nlm.nih.gov/)

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用电子采集和管理系统采集与管理病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统